Daily non-political popular news in brief.

New cancer weapon: nuclear nanocapsules

Rice University chemists have found a way to package some of nature's most powerful radioactive particles inside carbon nanotubes. Alpha-particle radiation is so powerful that cancer cells can be destroyed with just one direct hit from an alpha particle on a cell nucleus. Rice's researchers hope to use their new technology to target tiny tumors and even lone leukemia cells. Their research is available online from the journal Small.

Read more »

Keywords: cancer, weapon, nuclear, nanocapsules, nanocapsule

« Previous | Next »

Similar news on "New cancer weapon: nuclear nanocapsules":

1. Two studies: Speeding development of novel tracer for prostate cancer
   01-02-2007 · EurekAlert!
   The collaborative work being performed by professionals across medical disciplines in the promising area of molecular imaging -- from research scientists to nuclear medicine physicians, urologists, radiochemists and even veterinarians -- provides encouraging news in fighting prostate cancer. This type of progressive -- or translational -- research can be seen in two papers published in the January issue of the Journal of Nuclear Medicine.
   Similar news · Read more »
   
2. Breast cancer treatment heats up
   03-06-2007 · EurekAlert!
   In the March Journal of Nuclear Medicine, researchers demonstrate that miniscule bioprobes could be produced and used with molecularly targeted therapeutic heat to kill malignant breast cancer cells -- without damaging nearby healthy tissue.
   Similar news · Read more »
   
3. A study by the MUHC and McGill University opens a new door to understanding cancer
   08-09-2007 · EurekAlert!
   An in-depth understanding of the mechanisms that trigger cancer cell growth is vital to the development of more targeted treatments for the disease. An article published in the Aug. 3 issue of Molecular Cell provides a key to these mechanisms that may prove crucial in the future. The paper is co-authored by Dr. Morag Park, director of the MUHC Molecular Oncology Group, and Dr. Kalle Gehring, head of the Nuclear Magnetic Resonance Laboratory of the McGill University biochemistry department.
   Similar news · Read more »
   
4. New weapon to fight leukemia
   08-23-2007 · EurekAlert!
   A new study indicates that the drug FTY720 prevents disease in a mouse model of two leukemias -- blast crisis chronic myeloid leukemia and acute lymphocytic leukemia -- caused by the cancer protein BCR-ABL. As the drug also induced cell lines from humans with these leukemias to die in vitro the authors suggest that FTY720 should be considered by researchers and clinicians developing new approaches to treat CML-BC and ALL.
   Similar news · Read more »
   
5. Sandia computer simulation monitors traffic in contraband nuclear material
   01-17-2007 · EurekAlert!
   A Sandia National Laboratories researcher has developed a simulation program designed to track the illicit trade in fissile and nonfissile radiological material well enough to predict who is building the next nuclear weapon and where they are doing it.
   Similar news · Read more »
   
6. FDG-PET imaging clearly predicts lung cancer patients' response to chemotherapy
   05-09-2007 · EurekAlert!
   An earlier indication of whether chemotherapy benefits non-small cell lung cancer patients -- provided by positron emission tomography (PET) imaging -- can guide doctors in offering them better care, according to researchers in the May Journal of Nuclear Medicine.
   Similar news · Read more »
   
7. Electric fields have potential as a cancer treatment
   08-02-2007 · EurekAlert!
   Low-intensity electric fields can disrupt the division of cancer cells and slow the growth of brain tumors, suggest laboratory experiments and a small human trial, raising hopes that electric fields will become a new weapon for stalling the progression of cancer. The August 2007 issue of Physics Today describes the mechanisms by which the electric fields do their work.
   Similar news · Read more »
   
8. Patients need to know that nuclear medicine procedures can trigger radiation alarms
   12-06-2007 · EurekAlert!
   Twenty million nuclear medicine procedures that detect and evaluate heart disease, brain disorders and cancer -- and that use radiopharmaceuticals to treat overactive thyroids and some cancers -- are performed each year. While health care providers in many facilities do provide patients with adequate information about nuclear medicine procedures, there's room for improvement, says a study supported by the Centers of Disease Control and Prevention and the Agency for Healthcare Research and Quality that appears in the December Journal of Nuclear Medicine.
   Similar news · Read more »
   
9. Hybrid molecule causes cancer cells to self-destruct
   01-03-2007 · EurekAlert!
   By joining a sugar to a short-chain fatty acid compound, Johns Hopkins researchers have developed a two-pronged molecular weapon that kills cancer cells in lab tests.
   Similar news · Read more »
   
10. Quantitative PET imaging finds early determination of effectiveness of cancer treatment
    10-23-2007 · EurekAlert!
    With positron emission tomography imaging, seeing is believing: evaluating a patient's response to chemotherapy for non-Hodgkin lymphoma typically involves visual interpretation of scans of cancer tumors. Researchers have found that measuring a quantitative index -- one that reflects the reduction of metabolic activity after chemotherapy first begins -- adds accurate information about patients' responses to first-line chemotherapy, according to a study in the October issue of the Journal of Nuclear Medicine.
    Similar news · Read more »